Tandem Diabetes Care | TNDM - Assets


Tandem Diabetes Care reported $881.11M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Accuray USD 456.82M 13.42M Sep/2025
Align Technology USD 6.23B 141K Dec/2025
AtriCure USD 654.18M 18.74M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Cooper Companies USD 12.42B 29.4M Dec/2025
Dexcom USD 6.34B 1.16B Dec/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
Globus Medical USD 5.3B 207.12M Dec/2025
ICU Medical USD 4.05B 52.39M Dec/2025
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.19B 161.1M Dec/2025
Integra LifeSciences USD 3.6B 44.45M Dec/2025
Intuitive Surgical USD 20.46B 1.11B Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Masimo USD 1.7B 118.6M Dec/2025
Medtronic USD 91.48B 139M Dec/2025
Merit Medical Systems USD 2.69B 54.92M Dec/2025
Orthofix International USD 850.65M 18.04M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Stryker USD 47.84B 787M Dec/2025
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teleflex USD 6.95B 924.7M Dec/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025